Korea Investment CORP Has $59.63 Million Stock Holdings in Veeva Systems Inc. $VEEV

Key Points

• Korea Investment CORP trimmed its Veeva stake by 21.8% in Q3 to 200,163 shares, valued at about $59.63 million.
• Veeva reported a Q4 beat—EPS $2.06 vs. $1.94 consensus and revenue $835.95M (+16% y/y)—and issued FY27 and Q1 guidance while authorizing a $2.0 billion share buyback (up to 5.5% of shares).
• Several large institutions (Alphinity, Norges Bank, Durable, AQR, Schroder) have built or increased sizeable positions, leaving institutional ownership at ~88%, while analyst sentiment is mixed with price‑target cuts but an overall "Moderate Buy" average target of about $284.91.

Korea Investment CORP lowered its position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 21.8% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 200,163 shares of the technology company's stock after selling 55,644 shares during the quarter. Korea Investment CORP owned 0.12% of Veeva Systems worth $59,631,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in VEEV. Alphinity Investment Management Pty Ltd acquired a new position in Veeva Systems during the third quarter worth $422,241,000. Norges Bank bought a new stake in Veeva Systems during the 2nd quarter worth about $384,265,000. Durable Capital Partners LP bought a new position in shares of Veeva Systems in the 2nd quarter valued at about $281,351,000. AQR Capital Management LLC increased its position in shares of Veeva Systems by 111.7% in the second quarter. AQR Capital Management LLC now owns 1,838,046 shares of the technology company's stock valued at $526,508,000 after acquiring an additional 969,905 shares during the last quarter. Finally, Schroder Investment Management Group raised its holdings in Veeva Systems by 1,039.4% during the second quarter. Schroder Investment Management Group now owns 1,014,974 shares of the technology company's stock worth $292,292,000 after acquiring an additional 925,896 shares in the last quarter. 88.20% of the stock is owned by institutional investors.

Veeva Systems Price Performance

Shares of NYSE VEEV opened at $195.89 on Monday. The business has a fifty day moving average price of $203.47 and a two-hundred day moving average price of $246.91. The stock has a market capitalization of $32.20 billion, a PE ratio of 36.21, a P/E/G ratio of 1.35 and a beta of 1.09. Veeva Systems Inc. has a fifty-two week low of $168.13 and a fifty-two week high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last released its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The company had revenue of $835.95 million for the quarter, compared to analyst estimates of $810.95 million. During the same period in the prior year, the firm posted $1.74 EPS. Veeva Systems's quarterly revenue was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, equities analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current year.

Veeva Systems announced that its Board of Directors has authorized a share buyback program on Monday, January 5th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the technology company to reacquire up to 5.5% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

VEEV has been the topic of several recent analyst reports. Weiss Ratings lowered Veeva Systems from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday, January 12th. Canaccord Genuity Group cut their price objective on Veeva Systems from $280.00 to $235.00 and set a "hold" rating for the company in a report on Thursday. Wall Street Zen cut shares of Veeva Systems from a "buy" rating to a "hold" rating in a research note on Saturday, December 6th. Barclays dropped their price target on shares of Veeva Systems from $305.00 to $250.00 and set an "overweight" rating on the stock in a research report on Wednesday, February 25th. Finally, Oppenheimer decreased their price objective on shares of Veeva Systems from $325.00 to $275.00 and set an "outperform" rating for the company in a research report on Tuesday, February 24th. Seventeen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $284.91.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Q4 beats and raised outlook — Veeva reported revenue of ~$836M (+16% y/y) and non‑GAAP EPS of $2.06, above consensus, and provided FY27 guidance that came in ahead of some estimates, which drove the initial rally. Article Title
• Positive Sentiment: AI and product roadmap cited as growth drivers — Management emphasized “agentic” AI initiatives and CRM expansion (CRM targeted to be ~10% of revenue by 2030), positioning Veeva to capture higher‑value services and offset broader software AI fears. Article Title
• Positive Sentiment: Analyst support and buy ratings remain — Several firms reaffirmed or raised ratings/targets (e.g., Stifel raised target to $245; Truist reaffirmed buy), keeping institutional sentiment constructive despite some cuts. Article Title
• Neutral Sentiment: Earnings call detail available for deeper read — The full Q4 earnings call/transcript provides color on customer uptake, AI timing and margin outlook; useful for investors who want to judge execution risk vs opportunity. Article Title
• Neutral Sentiment: Technical/volume context — Trading volume was a bit below average and the stock remains under its 50‑ and 200‑day moving averages, which can limit near‑term upside until momentum recovers. (See market data summary above.)
• Negative Sentiment: Price‑target cuts and cautious notes — Multiple firms trimmed price targets (Canaccord, Piper Sandler, Needham, RBC, Wells Fargo among others) citing decelerating growth, margin pressure or to reflect model changes—these headlines trimmed upside and likely capped the post‑earnings rally. Article Title
• Negative Sentiment: Ongoing AI disruption debate — Despite Veeva’s positioning, some investors remain worried about how AI will change software economics and competitive dynamics; a few analysts argue AI risk and growth normalization justify a more cautious stance. Article Title

Insider Transactions at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of the stock in a transaction dated Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the sale, the insider directly owned 23,204 shares in the company, valued at $5,370,101.72. This represents a 4.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 10.30% of the stock is owned by insiders.

Veeva Systems Profile

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.